Gifts and payments to US doctors from drug firms are seen by some as encouraging unnecessary prescriptions. Do such transfers make any difference and will President Obama’s healthcare reform help, by forcing companies to disclose them? Research by Eric Campbell, professor of medicine at Massachusetts General Hospital, is cited. Tom Stossel, professor of medicine at Brigham and Women’s Hospital, is also quoted.
